Drug-loaded mesoporous silica nanoparticle for prevention and treatment of brain cancers or brain metastases
US12274688B2 · kind B2 · utility
0Cited by
1References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 13, 2022 |
| Grant date | Apr 15, 2025 |
| Priority date | — |
| Expiry date | Oct 13, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to a method of preventing or treating brain cancers or brain metastases with mesoporous silica nanoparticles (MSNs) loaded with taxane-based chemotherapeutic drugs, in particular paclitaxel (PTX), cabazitaxel (CTX) or docetaxel (DTX), and the MSNs loaded with PTX, CTX or DTX.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.